-
1
Gemcitabine combined with baicalein exerts antiviral activity against PEDV by inhibiting the entry and replication phases
Published 2025-02-01Subjects: Get full text
Article -
2
Oncolytic influenza virus enhances killing effect of gemcitabine against pancreatic cancer cells
Published 2025-01-01Subjects: Get full text
Article -
3
-
4
An exploratory study of INPP4B, a biomarker of gemcitabine chemoresistance in pancreatic cancer
Published 2024-12-01Subjects: Get full text
Article -
5
Solubility of gemcitabine (an anticancer drug) in supercritical carbon dioxide green solvent: Experimental measurement and thermodynamic modeling
Published 2025-02-01Subjects: “…Gemcitabine…”
Get full text
Article -
6
Cancer-associated fibroblast-derived COL17A1 promotes gemcitabine resistance and tumorigenesis in pancreatic cancer cells by interacting with ACTN4
Published 2025-02-01Subjects: “…Gemcitabine…”
Get full text
Article -
7
Epithelial–Mesenchymal Transition Suppression by ML210 Enhances Gemcitabine Anti-Tumor Effects on PDAC Cells
Published 2025-01-01Subjects: Get full text
Article -
8
COMBINED TREATMENT OF LOCALLY-ADVANCED BLADDER CANCER
Published 2016-01-01Subjects: Get full text
Article -
9
Novel Approaches to Monitor Pharmacokinetics and Metabolism of Gemcitabine-Ibandronate Conjugate in Mice and Dogs
Published 2025-01-01Subjects: Get full text
Article -
10
-
11
Study protocol: multi-centre, randomised controlled clinical trial exploring stromal targeting in locally advanced pancreatic cancer; STARPAC2
Published 2025-01-01Subjects: Get full text
Article